COMP <GO>
CLX vs AMZN // FREE CASH FLOW YIELD
Clorox Company (The) (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: CLX 8
— AMZN 3
▲ FREE CASH FLOW YIELD LEADER: CLX
LAST: $88.00 (-0.76%) • MKT CAP: $10.72B
fcf-yield
7.10%
LAST: $240.35 (-1.41%) • MKT CAP: $2.59T
fcf-yield
-1.81%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLX VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CLX | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 45.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.20% | 17.61% | +19.59 | CLX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.9x | 15.8x | -4.85 | CLX | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 7.10% | -1.81% | +8.91 | CLX | /fcf-yield <GO> |
| Operating Margin | 14.20% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 11.60% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 0.20% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 5.61% | 0.00% | +5.61 | CLX | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 3.32 | -0.39 | AMZN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 6/9 | +1.00 | CLX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.70% | 6.73% | -0.03 | CLX | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.8 | 38.3 | +15.58 | CLX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.93 | 1.46 | -0.53 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.1x | 22.8x | -10.65 | CLX | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $10.72B | $2.59T | -$2.58T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CLX REV | AMZN REV | CLX GROSS % | AMZN GROSS % | CLX FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $7.10B | $0 | 45.2% | — | $761.0M | $10.56B |
| FY 2024 | $7.09B | $0 | 43.0% | — | $483.0M | $42.95B |
| FY 2023 | $7.39B | $0 | 44.0% | — | $825.5M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLX // BETA 0.93
AMZN // BETA 1.46